In addition to Cerevast’s initial product offerings for stroke recovery and improved sleep quality, the company has a deep portfolio of technologies for future products in the following areas:

  • Home use version of the Neurosonx SR for post-stroke recovery
  • Transcranial ultrasound therapy for subarachnoid hemorrhage and prevention of vasospasm
  • Ultrasound plus microspheres for acute stroke treatment
  • Microsphere enhanced drug delivery to brain tissues
  • Transcranial ultrasound for the treatment of migraine
  • Transdermal electrical neurostimulation for cognitive enhancement
  • Transcranial ultrasound therapy for drug resistant depression
Pipeline Image

These additional programs coupled with Cerevast’s strong R&D team in Redmond, Washington uniquely positions the company to expand its portfolio of neurologic products into the future.